Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2017 1
2018 2
2020 4
2021 2
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
Saceda-Corralo D, Moustafa F, Moreno-Arrones Ó, Jaén-Olasolo P, Vañó-Galván S, Camacho F. Saceda-Corralo D, et al. J Drugs Dermatol. 2022 Jul 1;21(7):742-747. doi: 10.36849/JDD.6610. J Drugs Dermatol. 2022. PMID: 35816059
OBJECTIVE: The main objective was to describe the safety profile of mesotherapy with dutasteride in real clinical practice in a large cohort of patients with androgenetic alopecia. ...No serious or sexual adverse events were detected. CONCLUSION: Mesotherapy
OBJECTIVE: The main objective was to describe the safety profile of mesotherapy with dutasteride in real clinical practice in …
Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia.
Saceda-Corralo D, Rodrigues-Barata AR, Vañó-Galván S, Jaén-Olasolo P. Saceda-Corralo D, et al. Int J Trichology. 2017 Jul-Sep;9(3):143-145. doi: 10.4103/ijt.ijt_73_16. Int J Trichology. 2017. PMID: 28932074 Free PMC article. No abstract available.
Systematic review of mesotherapy: a novel avenue for the treatment of hair loss.
Gupta AK, Polla Ravi S, Wang T, Talukder M, Starace M, Piraccini BM. Gupta AK, et al. J Dermatolog Treat. 2023 Dec;34(1):2245084. doi: 10.1080/09546634.2023.2245084. J Dermatolog Treat. 2023. PMID: 37558233 Free article. Review.
Mesotherapy is a technique by which lower doses of therapeutic agents and bioactive substances are administered by intradermal injections to the skin. ...Of the 416 records identified, 27 articles met the inclusion criteria. To date, mesotherapy using 6 classes of a
Mesotherapy is a technique by which lower doses of therapeutic agents and bioactive substances are administered by intradermal inject
Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review.
Herz-Ruelas ME, Álvarez-Villalobos NA, Millán-Alanís JM, de León-Gutiérrez H, Ocampo-Garza SS, Gómez-Flores M, Grimalt R. Herz-Ruelas ME, et al. Skin Appendage Disord. 2020 Nov;6(6):338-345. doi: 10.1159/000510697. Epub 2020 Oct 9. Skin Appendage Disord. 2020. PMID: 33313048 Free PMC article. Review.
Mesotherapy could be a feasible alternative to avoid systemic exposure and side effects [J Pan-Arab League Dermatologist. 2009 Feb;20(1):137-45]. ...Although both interventions favor over placebo, there are not enough data to reliably compare outcomes obtained between both
Mesotherapy could be a feasible alternative to avoid systemic exposure and side effects [J Pan-Arab League Dermatologist. 2009 Feb;20
What's New in Therapy for Male Androgenetic Alopecia?
Saceda-Corralo D, Domínguez-Santas M, Vañó-Galván S, Grimalt R. Saceda-Corralo D, et al. Am J Clin Dermatol. 2023 Jan;24(1):15-24. doi: 10.1007/s40257-022-00730-y. Epub 2022 Sep 28. Am J Clin Dermatol. 2023. PMID: 36169916
While there are different treatments to stop hair loss and improve hair density, the 5-alpha reductase inhibitors have demonstrated to be effective in improving androgenetic alopecia in men and can maintain a positive response for many years. Oral finasteride 1 mg is a US FDA-app …
While there are different treatments to stop hair loss and improve hair density, the 5-alpha reductase inhibitors have demonstrated to be ef …
Two Cases of Paradoxical Nonscarring Alopecia after Mesotherapy with Dutasteride.
Reguero Del Cura L, De Quintana Sancho A, Rubio Lombraña M, López Sundh AE, González López MA. Reguero Del Cura L, et al. Skin Appendage Disord. 2022 Jan;8(1):46-48. doi: 10.1159/000518043. Epub 2021 Aug 18. Skin Appendage Disord. 2022. PMID: 35118130 Free PMC article.
Alopecia after mesotherapy with dutasteride is an extremely rare complication. Dutasteride is a second-generation 5a-reductase enzyme inhibitor that decreases serum dihydrotestosterone levels by 90%. ...We present 2 cases of patchy alopecia after mesothera
Alopecia after mesotherapy with dutasteride is an extremely rare complication. Dutasteride is a second-generation 5a-re …
Angioedema-like contact dermatitis caused by mesotherapy with dutasteride.
Magdaleno-Tapial J, Valenzuela-Oñate C, García-Legaz-Martínez M, Martínez-Domenech Á, Alonso-Carpio M, Talamantes CS, Zaragoza-Ninet MG, Zaragoza-Ninet V. Magdaleno-Tapial J, et al. Contact Dermatitis. 2020 Sep;83(3):246-247. doi: 10.1111/cod.13585. Epub 2020 Jul 1. Contact Dermatitis. 2020. PMID: 32356373 No abstract available.
Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.
Moftah N, Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B, Ibrahim M. Moftah N, et al. J Eur Acad Dermatol Venereol. 2013 Jun;27(6):686-93. doi: 10.1111/j.1468-3083.2012.04535.x. Epub 2012 Apr 6. J Eur Acad Dermatol Venereol. 2013. PMID: 22486925
OBJECTIVE: Evaluation of the efficacy and safety of mesotherapy using dutasteride-containing preparation in treatment of FPHL. ...Ultrastructural evaluation was done for three patients. RESULTS: After mesotherapy with dutasteride-containing preparation …
OBJECTIVE: Evaluation of the efficacy and safety of mesotherapy using dutasteride-containing preparation in treatment of FPHL. …
16 results